000 01205 a2200349 4500
005 20250518071014.0
008 ####s 0 0 eng d
022 _a2041-1723
024 7 _a10.1038/s41467-019-13151-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMichaelis, Katherine A
245 0 0 _aPublisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.
_h[electronic resource]
260 _bNature communications
_cNov 2019
300 _a5257 p.
_bdigital
500 _aPublication Type: Published Erratum
700 1 _aNorgard, Mason A
700 1 _aZhu, Xinxia
700 1 _aLevasseur, Peter R
700 1 _aSivagnanam, Shamilene
700 1 _aLiudahl, Shannon M
700 1 _aBurfeind, Kevin G
700 1 _aOlson, Brennan
700 1 _aPelz, Katherine R
700 1 _aRamos, Diana M Angeles
700 1 _aMaurer, H Carlo
700 1 _aOlive, Kenneth P
700 1 _aCoussens, Lisa M
700 1 _aMorgan, Terry K
700 1 _aMarks, Daniel L
773 0 _tNature communications
_gvol. 10
_gno. 1
_gp. 5257
856 4 0 _uhttps://doi.org/10.1038/s41467-019-13151-z
_zAvailable from publisher's website
999 _c30315078
_d30315078